Pfizer is teaming up with a Chinese biotech on a $10.5 billion cancer drug deal May 29, 2026 · Cris Tolomia The U.S. pharma giant will pay $650 million upfront to China's Innovent Biologics to co-develop 12 early-stage oncology programs Read more »
.png?branch=production&format=jpg&width=1024)
.jpg?branch=production&format=jpg&width=1024)
.jpg?branch=production&format=jpg&width=1024)
.JPG?branch=production&format=jpg&width=1024)
.jpg?branch=production&format=jpg&width=1024)
.png?branch=production&format=jpg&width=1024)
